Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial. [electronic resource]
Producer: 20030610Description: 1295-304 p. digitalISSN:- 1537-6591
- Adult
- Antiviral Agents -- therapeutic use
- CD4 Lymphocyte Count
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- HIV Infections -- blood
- HIV-1 -- drug effects
- Hepacivirus -- drug effects
- Hepatitis C
- Hepatitis C, Chronic -- blood
- Humans
- Interferons -- therapeutic use
- Male
- Middle Aged
- RNA, Viral -- blood
- Ribavirin -- therapeutic use
- Stavudine -- pharmacokinetics
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.